Xylem (XYL) Common Equity (2016 - 2026)
Xylem has reported Common Equity over the past 17 years, most recently at $11.0 billion for Q1 2026.
- For Q1 2026, Common Equity rose 1.46% year-over-year to $11.0 billion; the TTM value through Mar 2026 reached $11.0 billion, up 1.46%, while the annual FY2025 figure was $11.5 billion, 7.82% up from the prior year.
- Common Equity for Q1 2026 was $11.0 billion at Xylem, down from $11.5 billion in the prior quarter.
- Over five years, Common Equity peaked at $11.5 billion in Q4 2025 and troughed at $3.2 billion in Q2 2022.
- A 5-year average of $8.5 billion and a median of $10.2 billion in 2024 define the central range for Common Equity.
- Biggest five-year swings in Common Equity: surged 209.4% in 2023 and later grew 1.46% in 2026.
- Year by year, Common Equity stood at $3.5 billion in 2022, then surged by 190.49% to $10.2 billion in 2023, then rose by 4.63% to $10.6 billion in 2024, then increased by 7.82% to $11.5 billion in 2025, then fell by 4.36% to $11.0 billion in 2026.
- Business Quant data shows Common Equity for XYL at $11.0 billion in Q1 2026, $11.5 billion in Q4 2025, and $11.2 billion in Q3 2025.